IND submission is a major milestone in the life of your drug. We can provide all supporting analytical data to help ensure a smooth application process.
We have the expertise, flexibility, and resources to provide a full range of pharmaceutical API custom development services at every stage of the lifecycle.
We can provide lab-, kilo- and pilot-scale manufacturing for preclinical studies and all phases of clinical trials, supplying milligram to kilogram quantities.
Cambrex brings more than 40 years of generic API manufacturing experience to its pharmaceutical partners. From our sites in Italy, Sweden, and the USA, we are a leading global supplier of generic APIs.
Drug substance tech transfer sounds so simple on the surface, but it’s a complex activity carrying a number of technical, regulatory, and quality risks.
At Cambrex, we provide a range of technologies equipped to solve your API manufacturing challenges, and we are flexible enough to handle the most complex molecules.
If you’re looking to outsource drug product development to a CDMO, you need a collaborative partner who will engage you deeply to understand the unique needs of your project.
From pre-formulation to commercial manufacturing and packaging, you can trust Cambrex to deliver your complex dosage forms with the perfect combination of technology, expertise, and collaboration.
At Cambrex, we offer a tried and trusted approach to technology transfer, for scale-up or when transitioning to a different facility.
We are equipped to take on projects at any size or scale, offering established pediatric formulation and development expertise and to-scale manufacturing capabilities.
Biopharma companies at all stages of development, rely on our expertise and broad capabilities to produce the clinical trial supply of drug products they need, when they need them.
We can support you, at any size or stage, with a range of primary and secondary packaging solutions.
You can rely on our extensive portfolio of analytical development solutions and testing services to rapidly advance your molecule for the greatest chance of success.
Cambrex offers a comprehensive suite of testing services for complex biopharmaceuticals including standalone analytical R&D, method validation, release testing, ICH stability, and routine QC testing.
We’re solid state chemistry experts who can deliver timely, phase-appropriate solutions to optimize the physical stability of your API, develop a more bioavailable formulation or overcome other challenges.
Cambrex’s experienced analysts are well-equipped to ensure microbial testing is of the highest quality for our customers and delivered with a quick and reliable turnaround.
Cambrex and Q1 Scientific’s stability storage and sample management capabilities provide a variety of pharmaceutical storage conditions, with walk-in and reach-in chambers that meet all ICH Q1A requirements.
Cambrex is here to support you in early-phase development. Our development experts apply their ingenuity and skill to address your unique challenges.
Our teams of creative problem-solvers work closely with you to accelerate drug development timelines, optimize processes, and meet regulatory requirements.
We understand that the commercial phase of drug development can be challenging, especially when it comes to manufacturing at scale and meeting changing market demands.
Cambrex is a leading global supplier of more than 70 generic APIs, as well as intermediates and derivatives.
East Rutherford, NJ – December 5, 2017 – Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it is the recipient of the 2017 Educational Outreach Award for the Cambrex Charles City facility’s commitment in educating local schools about the benefits of chemistry and chemicals, as well as strong environmental, health, safety and security (EHS&S) efforts.
The Society of Chemical Manufacturers and Affiliates (SOCMA) presented this top industry honor to Cambrex as part of the annual Performance Improvement Awards ceremony at SOCMA’s 96th Annual Meeting and Member Dinner on December 4 in New York City. Seth Levine, Senior Director, Regulatory Affairs at Cambrex, accepted the award on behalf of Cambrex at the dinner.
The Cambrex Charles City site was recognized for its support of local high school students who implemented a program to reduce, reuse and recycle plastic containers used for holding water. Through the program, students reduced the number of containers being used by more than 70 percent per year, and they found a partner to take the used containers for repurposing them, thus promoting environmental savings as well. The combined efforts are expected to save the company more than $190,000 annually. Cambrex’s Charles City facility supported this effort as part of a collaboration with the Iowa North BIG program which brings area businesses and high school students together to solve real world manufacturing issues.
“We are pleased to receive this award from SOCMA, not only on behalf of the exemplary efforts of our employees, but also the students who were committed to making this project a success,” said Joe Nettleton, Vice President US Operations at Cambrex. “Our team looks forward to working with the students in the coming year and continuing to give back to the community as we move forward.”
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances. For more information, please visit www.cambrex.com
Since 1921, SOCMA has represented a diverse membership specialty chemical companies located around the world. To learn more, visit www.socma.com.
ChemStewards® is SOCMA’s flagship environmental, health, safety and security (EHS&S) continuous performance improvement program created from industry’s commitment to reducing its environmental footprint and to meet the unique needs of the specialty chemical industry. To learn more visit www.chemstewards.com.
Thank you for subscribing up to our newsletter.